David J. Schlanger
Executive Chairman, Director · Progyny, Inc.
- 2024
- Nov 13, 2025
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David J. Schlanger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Anevski - $1.93M in PGNY purchases and sales in the last 12 months
- Mark S. Livingston - $831K in PGNY purchases and sales in the last 12 months
- Kevin K. Gordon - $771K in PGNY purchases and sales in the last 12 months
- Allison Swartz - $402K in PGNY purchases and sales in the last 12 months
- Melissa B. Cummings - $310K in PGNY purchases and sales in the last 12 months
- Cheryl Scott - $196K in PGNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David J. Schlanger?
David J. Schlanger is a corporate insider, tracked as Executive Chairman, Director of Progyny, Inc. (PGNY). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David J. Schlanger last file a Form 4?
The most recent primary Form 4 on record is dated 13 November 2025, one of 5 filings going back to 2024.
Has David J. Schlanger been buying or selling stock?
Recorded transactions: 1 open-market purchase ($2.20M) and 0 open-market sales across all tracked filings.
